Please use this identifier to cite or link to this item: https://doi.org/10.1016/S1470-2045(08)70072-X
DC FieldValue
dc.titleScreening for gastric cancer in Asia: current evidence and practice
dc.contributor.authorLeung, W.K.
dc.contributor.authorWu, M.-s.
dc.contributor.authorKakugawa, Y.
dc.contributor.authorKim, J.J.
dc.contributor.authorYeoh, K.-g.
dc.contributor.authorGoh, K.L.
dc.contributor.authorWu, K.-c.
dc.contributor.authorWu, D.-c.
dc.contributor.authorSollano, J.
dc.contributor.authorKachintorn, U.
dc.contributor.authorGotoda, T.
dc.contributor.authorLin, J.-t.
dc.contributor.authorYou, W.-c.
dc.contributor.authorNg, E.K.
dc.contributor.authorSung, J.J.
dc.date.accessioned2016-11-17T08:39:31Z
dc.date.available2016-11-17T08:39:31Z
dc.date.issued2008-03
dc.identifier.citationLeung, W.K., Wu, M.-s., Kakugawa, Y., Kim, J.J., Yeoh, K.-g., Goh, K.L., Wu, K.-c., Wu, D.-c., Sollano, J., Kachintorn, U., Gotoda, T., Lin, J.-t., You, W.-c., Ng, E.K., Sung, J.J. (2008-03). Screening for gastric cancer in Asia: current evidence and practice. The Lancet Oncology 9 (3) : 279-287. ScholarBank@NUS Repository. https://doi.org/10.1016/S1470-2045(08)70072-X
dc.identifier.issn14702045
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/130638
dc.description.abstractGastric cancer is the second most common cause of death from cancer in Asia. Although surgery is the standard treatment for this disease, early detection and treatment is the only way to reduce mortality. This Review summarises the epidemiology of gastric cancer, and the evidence for, and current practices of, screening in Asia. Few Asian countries have implemented a national screening programme for gastric cancer; most have adopted opportunistic screening of high-risk individuals only. Although screening by endoscopy seems to be the most accurate method for detection of gastric cancer, the availability of endoscopic instruments and expertise for mass screening remains questionable-even in developed countries such as Japan. Therefore, barium studies or serum-pepsinogen testing are sometimes used as the initial screening tool in some countries, and patients with abnormal results are screened by endoscopy. Despite the strong link between infection with Helicobacter pylori and gastric cancer, more data are needed to define the role of its eradication in the prevention of gastric cancer in Asia. At present, there is a paucity of quality data from Asia to lend support for screening for gastric cancer. © 2008 Elsevier Ltd. All rights reserved.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1016/S1470-2045(08)70072-X
dc.sourceScopus
dc.typeReview
dc.contributor.departmentMEDICINE
dc.description.doi10.1016/S1470-2045(08)70072-X
dc.description.sourcetitleThe Lancet Oncology
dc.description.volume9
dc.description.issue3
dc.description.page279-287
dc.description.codenLOANB
dc.identifier.isiut000253622500037
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

530
checked on Jan 25, 2020

WEB OF SCIENCETM
Citations

505
checked on Jan 17, 2020

Page view(s)

145
checked on Jan 24, 2020

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.